Cardiac Ultrasound

Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.

Catch up on the top AI-related news and research in radiology over the past month.

The EchoGo Heart Failure platform is reportedly the only AI-powered technology to receive a CPT reimbursement code for echocardiography detection of heart failure with preserved ejection fraction.

Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.

Featuring a combination of automated measurement capabilities and workflow enhancements, the new AI-powered cardiovascular ultrasound platform also provides automated assessment of regional wall motion abnormalities.

The package of point-of-care ultrasound (POCUS) applications can reportedly facilitate rapid implementation of POCUS into imaging workflows.

The second version of the device reportedly detects T2/T3 fetal ultrasound views with 93.7 percent sensitivity and enables 63 percent of AIUM exam protocols without manual annotation.

Catch up on the top radiology content of the past week.

Catch up on the top AI-related news and research in radiology over the past month.

The artificial intelligence (AI)-powered applications reportedly allow clinicians to diagnose pulmonary edema and measure left ventricle ejection fraction within seconds.

One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.

Strain imaging analysis is one of the automated parameters included in the newly FDA-cleared Us2.v2 software for adjunctive review of echocardiographic images.

The addition of Caption AI to the handheld ultrasound device Vscan Air SL may facilitate optimal imaging for point-of-care cardiac evaluation.

Catch up on the top radiology content of the past week.

A recent pediatric clinical trial revealed that left ventricular opacification with the ultrasound agent Definity improved ejection fraction assessment for 80 percent of patients.

Designed for full-body imaging, the new modality reportedly offers a lightweight portable design, AI-powered tools and enhanced high-resolution images.

Recently cleared by the FDA, the iQ3 point-of-care ultrasound system reportedly offers new advances in 3D imaging capabilities.

Catch up on the top radiology content of the past week.

Reportedly providing enhanced imaging of structural heart disease, the minimally invasive X11 4t Mini 3D TEE ultrasound transducer facilitates use of the technology in smaller pediatric patients as well as high-risk ICU patients.

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.

Noting the challenges with angiography in the imaging of lower extremity revascularization, a panel of interventional radiologists, interventional cardiologists and vascular surgeons discussed emerging evidence that supports the use of intravascular ultrasound in facilitating improved outcomes in this high-risk patient population.

Catch up on the most viewed content on AI in radiology from 2023.

Catch up on the most well-read ultrasound articles from 2023.

Catch up on the top radiology content of the past week.

Providing 25 features to facilitate optimal workflow and user effectiveness, the portable Acuson Maple ultrasound can reportedly be utilized in a variety of clinical settings.

Catch up on the top radiology content of the past week.

Reimbursement for use of the artificial intelligence (AI)-powered EchoGo Heart Failure platform in hospital outpatient settings for Medicare and Medicaid patients is expected to increase from $99.81 to $284.88 in 2024.

Ultrasound and MRI findings from a new study suggest that greater carotid atherosclerosis and elevated white matter hyperintensities among women with the APOEe4 genotype, a strong risk factor for Alzheimer’s disease, are associated with increased PTSD symptoms in midlife women.

Combining phased and linear arrays on a single head, the Clarius PAL HD3 ultrasound device was unveiled at the recent American College of Emergency Physicians (ACEP) Scientific Assembly conference.